Jacobs Levy Equity Management
ABMD

Jacobs Levy Equity Management’s Abiomed Inc ABMD Stock Holding History

Jacobs Levy Equity Management’s Portfolio ABMD Stock Details ABMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q4 		– Sell
-15,235
Closed -$4.96M – 1119
2021
Q3 		$4.96M Buy
15,235
+11,650
+325% +$3.95M 0.03% 432
2021
Q2 		$1.12M Sell
3,585
-912
-20% -$280K 0.01% 721
2021
Q1 		$1.43M Sell
4,497
-4,889
-52% -$1.56M 0.01% 660
2020
Q4 		$3.04M Sell
9,386
-45,506
-83% -$12.6M 0.03% 491
2020
Q3 		$15.2M Sell
54,892
-17,589
-24% -$5.07M 0.16% 148
2020
Q2 		$17.5M Buy
+72,481
New +$14.6M 0.19% 135
2020
Q1 		– Sell
-27,569
Closed -$4.7M – 1125
2019
Q4 		$4.7M Buy
+27,569
New +$5.11M 0.05% 386
2018
Q4 		– Sell
-658
Closed -$296K – 1098
2018
Q3 		$296K Sell
658
-11,523
-95% -$4.54M ﹤0.01% 868
2018
Q2 		$4.98M Sell
12,181
-13,192
-52% -$4.78M 0.08% 306
2018
Q1 		$7.38M Sell
25,373
-7,218
-22% -$1.83M 0.12% 218
2017
Q4 		$6.11M Buy
32,591
+11,893
+57% +$2.22M 0.11% 242
2017
Q3 		$3.49M Sell
20,698
-9,190
-31% -$1.39M 0.07% 314
2017
Q2 		$4.28M Buy
29,888
+550
+2% +$73.9K 0.09% 262
2017
Q1 		$3.67M Buy
29,338
+16,068
+121% +$1.86M 0.07% 308
2016
Q4 		$1.5M Buy
13,270
+2,250
+20% +$261K 0.03% 469
2016
Q3 		$1.42M Buy
+11,020
New +$1.32M 0.03% 495

Other funds holding ABMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $500M AUM 25.3% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Jacobs Levy Equity Management's ABMD Position: Q4 2021 in Review

Jacobs Levy Equity Management sold out of Abiomed Inc (ABMD) in Q4 2021, closing a stake of 15,235 shares — an estimated $4.96M sold.

Jacobs Levy Equity Management first reported a position in ABMD in Q3 2016 and held it in 16 quarters. The position peaked at $17.5M in Q2 2020. 496 funds tracked by Wall St. Rank hold ABMD as of Q4 2021.

  • Jacobs Levy Equity Management reported no remaining Abiomed Inc position as of Q4 2021 after selling out during the quarter.
  • Jacobs Levy Equity Management sold 15,235 Abiomed Inc shares in Q4 2021, an estimated $4.96M.
  • Jacobs Levy Equity Management first reported a position in Abiomed Inc in Q3 2016 and held it in 16 quarters.
  • Jacobs Levy Equity Management's Abiomed Inc position peaked at $17.5M in Q2 2020.
  • 496 funds tracked by Wall St. Rank held Abiomed Inc as of Q4 2021.

Based on Jacobs Levy Equity Management's 13F filing for Q4 2021, filed 14 Feb 2022.